Total Payments
$4,446
2024 Payments
$942.27
Companies
30
Transactions
135
Medicare Patients
350
Medicare Billing
$28,357
Payment Breakdown by Category
Food & Beverage$4,278 (96.2%)
Research$107.34 (2.4%)
Other$42.25 (1.0%)
Education$17.84 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,278 | 131 | 96.2% |
| Unspecified | $107.34 | 1 | 2.4% |
| Entertainment | $42.25 | 2 | 1.0% |
| Education | $17.84 | 1 | 0.4% |
Payments by Type
General
$4,338
134 transactions
Research
$107.34
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTISSUE HOLDINGS INC. | $662.19 | 16 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, INC. | $472.53 | 4 | $0 (2019) |
| ABBVIE INC. | $387.04 | 9 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $362.08 | 11 | $0 (2024) |
| TISSUETECH, INC. | $301.73 | 9 | $0 (2021) |
| Glaukos Corporation | $258.82 | 7 | $0 (2023) |
| Johnson & Johnson Surgical Vision, Inc. | $234.42 | 10 | $0 (2024) |
| Dompe US, Inc. | $205.89 | 5 | $0 (2024) |
| RxSight Inc | $171.56 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $149.08 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $942.27 | 22 | BIOTISSUE HOLDINGS INC. ($187.31) |
| 2023 | $996.73 | 30 | BIOTISSUE HOLDINGS, INC. ($325.73) |
| 2022 | $871.51 | 35 | BioTissue Holdings, Inc. ($149.15) |
| 2021 | $420.63 | 16 | Kala Pharmaceuticals, Inc. ($125.00) |
| 2020 | $281.06 | 11 | TissueTech, Inc. ($108.28) |
| 2019 | $933.47 | 21 | PORTOLA PHARMACEUTICALS, INC. ($472.53) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/04/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $33.91 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/15/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR HANDPIECE, RXSIGHT INJECTOR CARTRIDGE | Food and Beverage | In-kind items and services | $34.42 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/09/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: OPTOMETRY | ||||||
| 09/20/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/28/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/19/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Ophthalmology | ||||||
| 08/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $42.75 | General |
| Category: Ophthalmology | ||||||
| 07/22/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $28.66 | General |
| 07/10/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $116.71 | General |
| Category: EYE CARE | ||||||
| 07/09/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Dry eyes | ||||||
| 06/10/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $113.69 | General |
| 06/03/2024 | Johnson & Johnson Surgical Vision, Inc. | Tecnis Simplicity (Device) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Optics | ||||||
| 05/09/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $122.13 | General |
| Category: SOLUTION/ DROPS | ||||||
| 04/23/2024 | Johnson & Johnson Surgical Vision, Inc. | Tecnis IOL (Device) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Optics | ||||||
| 04/18/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $37.28 | General |
| Category: OPTOMETRY | ||||||
| 04/01/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $18.05 | General |
| 03/27/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 02/06/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Ophthalmology | ||||||
| 01/29/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $26.91 | General |
| 01/24/2024 | Thea Pharma Inc. | — | Food and Beverage | In-kind items and services | $26.31 | General |
| 12/20/2023 | Glaukos Corporation | iStent infinite Trabecular Micro-Bypass System Model iS3 (Device), iStent infinite Trabecular Micro-Bypass System Model iS3 | Food and Beverage | Cash or cash equivalent | $19.22 | General |
| Category: Glaucoma | ||||||
| 12/20/2023 | Glaukos Corporation | KXL system (not refurbished) (Device) | Food and Beverage | Cash or cash equivalent | $18.84 | General |
| Category: Corneal Health | ||||||
| 11/14/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: EYE CARE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5 | Glaukos Corporation | $107.34 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 95 | 130 | $30,665 | $8,111 |
| 2022 | 2 | 32 | 42 | $10,690 | $3,219 |
| 2021 | 4 | 98 | 126 | $32,700 | $7,975 |
| 2020 | 6 | 125 | 153 | $25,545 | $9,051 |
Total Patients
350
Total Services
451
Medicare Billing
$28,357
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 28 | $8,260 | $2,553 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $4,200 | $2,539 | 60.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 33 | $6,435 | $2,034 | 31.6% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 18 | 34 | $10,370 | $608.60 | 5.9% |
| 92134 | Imaging of retina | Office | 2023 | 13 | 14 | $1,400 | $376.45 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 25 | $7,375 | $2,347 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 17 | $3,315 | $871.60 | 26.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 43 | $12,685 | $3,503 | 27.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 31 | $6,045 | $2,005 | 33.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $3,600 | $1,652 | 45.9% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2021 | 20 | 34 | $10,370 | $816.00 | 7.9% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 42 | 70 | $11,200 | $4,581 | 40.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 20 | 20 | $5,100 | $2,054 | 40.3% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 18 | 18 | $4,500 | $1,348 | 30.0% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 17 | 17 | $2,550 | $634.83 | 24.9% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 17 | 17 | $1,700 | $347.00 | 20.4% |
| 76514 | Ultrasound of corneal structure and measurement | Office | 2020 | 11 | 11 | $495.00 | $86.90 | 17.6% |
About Dr. Mina Vanrachack, OD
Dr. Mina Vanrachack, OD is a Optometrist healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2018. The National Provider Identifier (NPI) number assigned to this provider is 1033687058.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mina Vanrachack, OD has received a total of $4,446 in payments from pharmaceutical and medical device companies, with $942.27 received in 2024. These payments were reported across 135 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,278).
As a Medicare-enrolled provider, Vanrachack has provided services to 350 Medicare beneficiaries, totaling 451 services with total Medicare billing of $28,357. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location San Antonio, TX
- Active Since 11/07/2018
- Last Updated 09/03/2020
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1033687058
Products in Payments
- PROKERA (Device) $560.76
- ANDEXXA (Biological) $472.53
- Cequa (Drug) $362.08
- XIIDRA (Drug) $235.41
- Prokera (Device) $215.85
- OXERVATE (Drug) $205.89
- DURYSTA (Drug) $186.24
- TEPEZZA (Biological) $145.30
- EYSUVIS (Drug) $142.63
- TEPEZZA (Drug) $124.99
- OZURDEX (Drug) $116.71
- TYRVAYA (Drug) $108.92
- VUITY (Drug) $107.51
- RXSIGHT CONTACT LENS (Device) $92.64
- LOTEMAX SM (Drug) $83.81
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) $78.92
- NFC-700 (Device) $42.25
- IACCESS (Device) $38.69
- IHEEZO (Drug) $37.28
- Catalys Laser System (Device) $37.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in San Antonio
Dr. Jeff Rabin, O.d., Ph.d, O.D., PH.D
Optometrist — Payments: $87,976
Optometrist $87,976
Dawn Rakich, O.d, O.D
Optometrist — Payments: $86,026
Optometrist $86,026
Carolyn Majcher, Od, OD
Optometrist — Payments: $78,622
Optometrist $78,622
Dr. Melanie Frogozo, O.d, O.D
Optometrist — Payments: $46,127
Optometrist $46,127
Arthur Medina, O.d, O.D
Optometrist — Payments: $26,484
Optometrist $26,484
Jeff Foster, Od, OD
Optometrist — Payments: $26,294
Optometrist $26,294